Log in to save to my catalogue

ILUVIEN ® Technology in the Treatment of center-involving Diabetic Macular edema: a Review of the Li...

ILUVIEN ® Technology in the Treatment of center-involving Diabetic Macular edema: a Review of the Li...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2216559317

ILUVIEN ® Technology in the Treatment of center-involving Diabetic Macular edema: a Review of the Literature

About this item

Full title

ILUVIEN ® Technology in the Treatment of center-involving Diabetic Macular edema: a Review of the Literature

Author / Creator

Publisher

London: Newlands Press

Journal title

Therapeutic delivery, 2018-08, Vol.9 (8), p.547-556

Language

English

Formats

Publication information

Publisher

London: Newlands Press

More information

Scope and Contents

Contents

Diabetic macular edema (DME) is one of the major causes of blindness, caused primarily by hyperglycemia and results from multiple pathological processes mostly secondary to increased levels of VEGF and other inflammatory cytokines. DME management includes control of systemic risk factors together with laser photocoagulation, frequent intraocular in...

Alternative Titles

Full title

ILUVIEN ® Technology in the Treatment of center-involving Diabetic Macular edema: a Review of the Literature

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2216559317

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2216559317

Other Identifiers

ISSN

2041-5990

E-ISSN

2041-6008

DOI

10.4155/tde-2018-0006

How to access this item